HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon U.S. sales advance 8.8% to $282.5 mil. in first quarter.

This article was originally published in The Rose Sheet

Executive Summary

REVLON FIRST-QUARTER U.S. SALES UP 8.8% TO $282.5 MIL. due in part to the continuing success of Revlon brand color cosmetics, including ColorStay and Age Defying, the company reported April 23. Revlon also attributed the sales gain to its "Very Currant" color promotion and its "alternative" Street Wear collection. Growth in the Almay Amazing, Clear Complexion and Time-Off brands contributed to the upbeat sales performance, Revlon said.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004094

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel